Why Docuvera > Current/Future Standards
Structured Labeling & Product Information
FDA SPL, ePI, EMA DADI, HL7 FHIR
Powering Consistent, Compliant Content from Core Data to Patient-Facing Formats
Global health authorities are evolving their expectations for how product information is created, reviewed, and distributed. Initiatives such as ePI (electronic Product Information), FDA SPL, and EMA’s DADI aim to replace disconnected document files with modular, metadata-driven content that is accessible, machine-readable, and compliant by design.
Docuvera enables life sciences organizations to transform regulatory labeling and product information into structured, multichannel-ready content—with full traceability across affiliates, submissions, and product variants.

As the FDA explores FHIR for labeling interoperability, Docuvera’s structured architecture supports content reuse in FHIR-convertible formats.
Each component is governed, versioned, and metadata-tagged—enabling reuse across markets, channels, and regulatory filings.
Docuvera simplifies this complexity by providing:
FDA SPL (Structured Product Labeling)
Region
U.S.
Purpose
XML-based labeling format for product submissions
Docuvera Alignment
Authors modular content compatible with SPL architecture
HL7 FHIR for Labeling
Region
U.S. / Global
Purpose
Enables digital interoperability of health content
Docuvera Alignment
Structured content blocks support mapping to FHIR outputs
ePI (Electronic Product Information)
Region
EU (EMA)
Purpose
Digital SmPC and PL formats for patients and HCPs
Docuvera Alignment
Enables modular authoring and variant management for machine-readable output
DADI
Region
Global
Purpose
Structured dataset model for variation and submission forms
Docuvera Alignment
Metadata-rich content aligns with structured digital application fields
Global Labeling Lifecycle Management
Region
Global
Purpose
Harmonize regulatory labeling across products, regions, and platforms
Docuvera Alignment
Provides end-to-end traceability, reuse, and change control